- Home
- MDBH vs TPST Comparison
MDBH vs TPST Comparison
Compare MDBH & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDBH
- TPST
- Stock Information
- Founded
- MDBH 1997
- TPST 2011
- Country
- MDBH United States
- TPST United States
- Employees
- MDBH N/A
- TPST N/A
- Industry
- MDBH
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- MDBH
- TPST Health Care
- Exchange
- MDBH Nasdaq
- TPST Nasdaq
- Market Cap
- MDBH 40.5M
- TPST 33.0M
- IPO Year
- MDBH 2023
- TPST N/A
- Fundamental
- Price
- MDBH $4.44
- TPST $7.76
- Analyst Decision
- MDBH
- TPST Hold
- Analyst Count
- MDBH 0
- TPST 3
- Target Price
- MDBH N/A
- TPST $30.00
- AVG Volume (30 Days)
- MDBH 3.5K
- TPST 80.4K
- Earning Date
- MDBH 08-12-2025
- TPST 08-07-2025
- Dividend Yield
- MDBH N/A
- TPST N/A
- EPS Growth
- MDBH N/A
- TPST N/A
- EPS
- MDBH 0.84
- TPST N/A
- Revenue
- MDBH $3,574,131.00
- TPST N/A
- Revenue This Year
- MDBH N/A
- TPST N/A
- Revenue Next Year
- MDBH N/A
- TPST N/A
- P/E Ratio
- MDBH $5.27
- TPST N/A
- Revenue Growth
- MDBH N/A
- TPST N/A
- 52 Week Low
- MDBH $3.61
- TPST $5.35
- 52 Week High
- MDBH $12.00
- TPST $28.34
- Technical
- Relative Strength Index (RSI)
- MDBH 50.35
- TPST 63.65
- Support Level
- MDBH $3.91
- TPST $6.11
- Resistance Level
- MDBH $4.71
- TPST $6.49
- Average True Range (ATR)
- MDBH 0.23
- TPST 0.35
- MACD
- MDBH -0.05
- TPST 0.03
- Stochastic Oscillator
- MDBH 49.53
- TPST 100.00
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.